Journal Changes for 2023

At the beginning of every new year, there are often changes in journals which may include additions, platform changes and cancellations. Though there are no cancellations this year, below are some changes for 2023.

The following titles are being added to our subscriptions because they meet our criteria for inclusion based on cost, usage, journal quality, and relevance.

  • Childhood Obesity
  • Clinical and Experimental Dermatology
  • Journal of Adolescent and Young Adult Oncology

New Platforms
The following journal titles will now be available on different platforms. Often this occurs when the professional society that publishes the journal begins working with or switches to a different commercial publisher.

JournalFormer PlatformNew Platform
American Journal of Clinical NutritionOxfordScienceDirect
American Journal of TransplantationWileyScienceDirect
British Journal of DermatologyWileyOxford University Press
Clinical Journal of the American Society of NephrologyAmerican Society of NephrologyOvid
Clinical Liver DiseaseWileyOvid
DermatitisOvidMary Ann Liebert
European Journal of EndocrinologyBioscientificOxford University Press
Hepatology CommunicationsWileyOvid
Journal of the American Society of NephrologyAmerican Society of NephrologyOvid
Journal of Leukocyte BiologyWileyOxford University Press
Journal of NutritionOxfordScienceDirect
Journal of Sexual MedicineWileyOxford University Press
Journal of Thrombosis and HaemostasisWileyScienceDirect
Laboratory InvestigationSpringer NatureScienceDirect
Liver TransplantationWileyOvid
Modern PathologySpringer NatureScienceDirect
NEJM Catalyst Innovations in Care Delivery Ovid; Also available on
NEJM Evidence Ovid; Also available on
New England Journal of Medicine Ovid; Also available on
Postgraduate Medical JournalBMJOxford University Press
Sexual Medicine ReviewsWileyOxford University Press

For the most current and complete access, please be sure to start your search for journals from our Website. Contact us at if you have questions or feedback, or if you're experiencing difficulties in accessing our collections.